Terms: = Head and neck cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Diagnosis
261 results:
1. Treatment of esophageal adenocarcinoma in patients with a history of bariatric surgery.
Nobel T; Sewell M; Boerner T; Bains MS; Bott MJ; Gerdes H; Gray K; Nishimura M; Park BJ; Shah P; Sihag S; Jones DR; Molena D
J Gastrointest Surg; 2024 Apr; 28(4):337-342. PubMed ID: 38583881
[TBL] [Abstract] [Full Text] [Related]
2. Investigating the causal role of the gut microbiota in esophageal cancer and its subtypes: a two-sample Mendelian randomization study.
Li J; Gao X; Sun X; Li H; Wei J; Lv L; Zhu L
BMC Cancer; 2024 Apr; 24(1):416. PubMed ID: 38575885
[TBL] [Abstract] [Full Text] [Related]
3. Ensembled CNN with artificial bee colony optimization method for esophageal cancer stage classification using SVM classifier.
Chempak Kumar A; Mubarak DMN
J Xray Sci Technol; 2024; 32(1):31-51. PubMed ID: 37980593
[TBL] [Abstract] [Full Text] [Related]
4. Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study.
Sijben J; Rainey L; Peters Y; Fitzgerald RC; Wani S; Kolb JM; Broeders MJM; Siersema PD
BMC Cancer; 2023 Nov; 23(1):1111. PubMed ID: 37964213
[TBL] [Abstract] [Full Text] [Related]
5. Population Based Time Trends in the Epidemiology and Mortality of Gastroesophageal Junction and Esophageal Adenocarcinoma.
Agarwal S; Bell MG; Dhaliwal L; Codipilly DC; Dierkhising RA; Lansing R; Gibbons EE; Leggett CL; Kisiel JB; Iyer PG
Dig Dis Sci; 2024 Jan; 69(1):246-253. PubMed ID: 37914889
[TBL] [Abstract] [Full Text] [Related]
6. Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett's Esophagus Patients Undergoing Endoscopic Eradication Therapy.
Smith ZL; Thorgerson AM; Dawson AZ; Wani S
Dig Dis Sci; 2023 Dec; 68(12):4439-4448. PubMed ID: 37863992
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1a Esophageal Adenocarcinoma: A Multicenter Study.
Kamboj AK; Goyal R; Vantanasiri K; Sachdeva K; Passe M; Lansing R; Garg N; Chandi PS; Ramirez FC; Kahn A; Fukami N; Wolfsen HC; Krishna M; Pai RK; Hagen C; Lee HE; Wang KK; Leggett CL; Iyer PG
Am J Gastroenterol; 2024 Apr; 119(4):662-670. PubMed ID: 37795907
[TBL] [Abstract] [Full Text] [Related]
8. [Barrett's esophagus: diagnosis, treatment and minimizing of risk].
Thorell A; Bednarska O; Jeremiasen M; Mottacki N; Lundell L
Lakartidningen; 2023 Sep; 120():. PubMed ID: 37746770
[TBL] [Abstract] [Full Text] [Related]
9. A Tissue Systems Pathology Test Outperforms the Standard-of-Care Variables in Predicting Progression in Patients With Barrett's Esophagus.
Davison JM; Goldblum JR; Duits LC; Khoshiwal AM; Bergman JJ; Falk GW; Diehl DL; Khara HS; Smolko C; Arora M; Siegel JJ; Critchley-Thorne RJ; Thota PN
Clin Transl Gastroenterol; 2023 Nov; 14(11):e00631. PubMed ID: 37622544
[TBL] [Abstract] [Full Text] [Related]
10. Identification of a diagnosis and Therapeutic Inflammatory Response-Related Gene Signature Associated with Esophageal Adenocarcinoma.
Xie Y; Li J; Tao Q; Zeng C; Chen Y
Crit Rev Eukaryot Gene Expr; 2023; 33(7):65-80. PubMed ID: 37602454
[TBL] [Abstract] [Full Text] [Related]
11. Neoplasms of the Ear Canal.
Raymond M
Otolaryngol Clin North Am; 2023 Oct; 56(5):965-976. PubMed ID: 37495430
[TBL] [Abstract] [Full Text] [Related]
12. Resident Esophageal Microbiota Dysbiosis Correlates with cancer Risk in Barrett's Esophagus Patients and Is Linked to Low Adherence to WCRF/AICR Lifestyle Recommendations.
Zaramella A; Arcidiacono D; Nucci D; Fabris F; Benna C; Pucciarelli S; Fassan M; Fantin A; De Re V; Cannizzaro R; Realdon S
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447211
[TBL] [Abstract] [Full Text] [Related]
13. Magnitude and Time-Trends of Post-Endoscopy Esophageal Adenocarcinoma and Post-Endoscopy Esophageal Neoplasia in a Population-Based Cohort Study: The Nordic Barrett's Esophagus Study.
Wani S; Holmberg D; Santoni G; Kauppila JH; Farkkila M; von Euler-Chelpin M; Shaheen NJ; Lagergren J
Gastroenterology; 2023 Oct; 165(4):909-919.e13. PubMed ID: 37279832
[TBL] [Abstract] [Full Text] [Related]
14. Categorizing Risks within Barrett's Esophagus To Guide Surveillance and Interception; Suggesting a New Framework.
Honing J; Fitzgerald RC
Cancer Prev Res (Phila); 2023 Jun; 16(6):313-320. PubMed ID: 37259801
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic Alterations from Barrett's Esophagus to Esophageal Adenocarcinoma.
Ergun P; Kipcak S; Bor S
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175524
[TBL] [Abstract] [Full Text] [Related]
16. cancer Risk in Barrett's Esophagus: A Clinical Review.
Beydoun AS; Stabenau KA; Altman KW; Johnston N
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046992
[TBL] [Abstract] [Full Text] [Related]
17. Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagus.
Luebeck J; Ng AWT; Galipeau PC; Li X; Sanchez CA; Katz-Summercorn AC; Kim H; Jammula S; He Y; Lippman SM; Verhaak RGW; Maley CC; Alexandrov LB; Reid BJ; Fitzgerald RC; Paulson TG; Chang HY; Wu S; Bafna V; Mischel PS
Nature; 2023 Apr; 616(7958):798-805. PubMed ID: 37046089
[TBL] [Abstract] [Full Text] [Related]
18. Antibiotic Exposure is Associated With a Risk of Esophageal Adenocarcinoma.
Thanawala SU; Kaplan DE; Falk GW; Beveridge CA; Schaubel D; Serper M; Yang YX
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2817-2824.e4. PubMed ID: 36967101
[TBL] [Abstract] [Full Text] [Related]
19. Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal cancers.
Rai V; Abdo J; Agrawal DK
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834728
[TBL] [Abstract] [Full Text] [Related]
20. Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatment.
Xiao H; Bertwistle D; Khela K; Middleton-Dalby C; Hall J
BMC Cancer; 2023 Feb; 23(1):186. PubMed ID: 36823552
[TBL] [Abstract] [Full Text] [Related]
[Next]